Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hybrid Nanoporous Gold-Cyclodextrin Nanosponge Platforms for Enhanced Model Contaminant Detection.

ACS applied polymer materials·2026
Same author

Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. <i>Cancers</i> 2022, <i>14</i>, 1630.

Cancers·2026
Same author

Trends in Inhibitors, Structural Modifications, and Structure-Function Relationships of Phosphodiesterase 4: A Review.

Biomolecules·2026
Same author

pH-Sensitive Dextrin-Based Nanosponges Crosslinked with Pyromellitic Dianhydride and Citric Acid: Swelling, Rheological Behavior, Mucoadhesion, and In Vitro Drug Release.

Gels (Basel, Switzerland)·2026
Same author

Redox responsive cyclodextrin-based drug delivery systems: a special insight to glutathione responsive CD-nanosponges.

Expert opinion on drug delivery·2026
Same author

Erratum to "Gemcitabine-loaded ICOS-Fc decorated nanosponges: a new chemo immunotherapy combination against pancreatic cancer". [Int. J. Pharm. 682 (2025) 125869].

International journal of pharmaceutics·2026

Related Experiment Video

Updated: Dec 3, 2025

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
10:10

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study

Published on: August 15, 2016

10.6K

Drug-Encapsulated Cyclodextrin Nanosponges.

Maria Tannous1,2, Fabrizio Caldera1, Gjylije Hoti1

  • 1Dipartimento di Chimica, Università di Torino, Torino, Italy.

Methods in Molecular Biology (Clifton, N.J.)
|October 28, 2020
PubMed
Summary
This summary is machine-generated.

Cyclodextrin nanosponges (CDNSs) are innovative drug delivery systems that enhance drug solubility, stability, and efficacy. These nanocarriers show great promise for overcoming bioavailability challenges and reducing side effects.

Keywords:
AntibacterialAnticancerAntiviralCyclodextrinEncapsulationGas deliveryMiscellaneousNanosponges

More Related Videos

Nanosponge Tunability in Size and Crosslinking Density
11:15

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

7.9K
Preparation and Characterization of SDF-1&#945;-Chitosan-Dextran Sulfate Nanoparticles
12:00

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Published on: January 22, 2015

12.8K

Related Experiment Videos

Last Updated: Dec 3, 2025

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
10:10

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study

Published on: August 15, 2016

10.6K
Nanosponge Tunability in Size and Crosslinking Density
11:15

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

7.9K
Preparation and Characterization of SDF-1&#945;-Chitosan-Dextran Sulfate Nanoparticles
12:00

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Published on: January 22, 2015

12.8K

Area of Science:

  • Polymer Chemistry
  • Materials Science
  • Pharmaceutical Sciences

Background:

  • Nanocarriers are crucial for improving drug delivery and therapeutic outcomes.
  • Cyclodextrins (CDs), cyclic glucopyranose oligomers, possess a lipophilic cavity capable of encapsulating various compounds.
  • Cyclodextrin-based cross-linked polymers, known as cyclodextrin nanosponges (CDNSs), are gaining attention for drug delivery applications.

Purpose of the Study:

  • To review the potential of cyclodextrin nanosponges (CDNSs) as advanced drug delivery systems.
  • To highlight the ability of CDNSs to address key bioavailability issues.
  • To detail registered patents and diverse applications of CDNSs.

Main Methods:

  • Review of existing literature and patents on cyclodextrin nanosponges.
  • Analysis of the structural properties and inclusion capabilities of cyclodextrins.
  • Evaluation of CDNSs for enhancing drug solubility, dissolution rate, and stability.

Main Results:

  • Cyclodextrin nanosponges effectively improve the solubility, dissolution rate, and stability of various drugs.
  • CDNSs demonstrate potential in increasing therapeutic efficacy and reducing adverse effects.
  • Numerous patents showcase the versatility of CDNSs across different pharmaceutical fields and drug classes.

Conclusions:

  • Cyclodextrin nanosponges represent a promising platform for developing innovative drug delivery systems.
  • CDNSs offer solutions for major bioavailability challenges, enhancing drug performance.
  • The broad applicability and patent landscape underscore the significance of CDNSs in pharmaceutical research.